Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Antitumor activity of macromomycin]

T Kato, N Yamanaka, S Katayama

    Gan to Kagaku Ryoho. Cancer & Chemotherapy
    |July 1, 1982
    PubMed
    Summary

    Macromomycin (MCR) exhibits potent antitumor activity against L1210 and P388 leukemia models, comparable to neocarzinostatin (NCS). However, MCR showed no significant effect on Lewis lung carcinoma survival.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Experimental and clinical studies on dysregulation of magnesium metabolism and the aetiopathogenesis of multiple sclerosis.

    Magnesium research·1992
    Same author

    Mechanism of proteinuria in nephrotic syndrome.

    Acta medica Okayama·1992
    Same author

    Effects of nicergoline on calcium and magnesium deposition in the central nervous system tissues of rats maintained on low-calcium diets.

    The Journal of international medical research·1992
    Same author

    Alpha 2-adrenergic receptors are involved in the suppression of luteinizing hormone release during acute fasting in the ovariectomized estradiol-primed rats.

    Neuroendocrinology·1992
    Same author

    [Anti-emetic effect and safety of single dose of ondansetron injection in double-blind comparison study with placebo].

    Gan to kagaku ryoho. Cancer & chemotherapy·1992
    Same author

    [Anti-emetic effect and safety of ondansetron tablet in double-blind comparison with placebo].

    Gan to kagaku ryoho. Cancer & chemotherapy·1992

    Area of Science:

    • Oncology
    • Pharmacology
    • Molecular Biology

    Context:

    • Macromomycin (MCR) is a polypeptide antibiotic with potential antitumor properties.
    • Evaluating MCR's efficacy is crucial for developing new cancer therapies.

    Purpose:

    • To investigate the in vitro and in vivo antitumor activity of macromomycin (MCR).
    • To compare MCR's efficacy against specific cancer cell lines and leukemia models with neocarzinostatin (NCS).

    Summary:

    • Macromomycin demonstrated equivalent cytostatic effects on L1210 cells in vitro compared to neocarzinostatin.
    • In vivo studies showed MCR had a similar impact on L1210 and P388 leukemia survival as NCS, irrespective of treatment schedules.
    • Macromomycin was found to be inactive against Lewis lung carcinoma survival.

    Impact:

    • These findings suggest MCR's potential as a therapeutic agent for certain leukemias.
    • Further research could explore MCR's mechanisms of action and its applicability in combination therapies.
    • The differential activity highlights the need for targeted application of MCR in cancer treatment.

    Related Experiment Videos